West Virginia HB5556 creates a pilot program for external reference pricing of high-cost prescription drugs in Medicaid.
West Virginia HB5556 authorizes the Department of Human Services to establish a pilot program applying external reference pricing for selected high-cost prescription drugs in the state Medicaid program. This program sets a maximum reimbursement rate based on the lowest price paid for the same or therapeutically equivalent drug in comparable industrialized nations. The pilot program will last up to three years, with annual reports to the Joint Committee on Government and Finance.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.